Please login to the form below
Covid-19
This page shows the latest Covid-19 news and features for those working in and with pharma, biotech and healthcare.
UK pharmacies to begin administering COVID-19 vaccinations
The UK has already approved three COVID-19 vaccines: Pfizer/BioNTech’s mRNA-based vaccine, AstraZeneca(AZ)/Oxford University’s vaccine and most recently Moderna’s vaccine. ... Currently, over 2.6 million people in the UK have received the first
Latest news
-
PHE study finds people who have had COVID-19 can still transmit the virus
A study from Public Health England (PHE) has found that although people who have had COVID-19 may have immunity against the virus for ‘at least five months’, they could still ... The SIREN study scientists also detected 44 potential cases of COVID-19
-
New dosing option for AZ’s Imfinzi approved in the EU and UK
The additional option extends dosing from every two weeks to every four weeks, enabling patients to reduce their medical visits – an important factor in the current COVID-19 pandemic.
-
Celltrion’s investigational mAb cuts COVID-19 recovery time
Within this patient population, approximately 60% of patients with moderate symptoms also suffered from COVID-19-related pneumonia. ... For patients with moderate COVID-19, this reduction was even higher, at 68%.
-
J&J could launch its single-dose COVID-19 vaccine in March
US pharma Johnson &Johnson (J&J) is planning to launch its single-dose COVID-19 vaccine in March, according to the company’s chief scientific officer Paul Stoffels. . ... J&J previously signed an advance purchase agreement with the European Commission
-
Sinovac’s COVID-19 vaccine demonstrates 50.4% efficacy in Brazilian trial data
The primary immunogenic endpoint in the trials was the seroconversion of neutralising antibodies against the SARS-CoV-2 virus, which causes COVID-19. ... The researchers maintained that the vaccine could still provide ‘satisfying protection’ against
More from news
Approximately 294 fully matching, plus 65 partially matching documents found.
Latest Intelligence
-
2021: the year of decentralisation in drug development
Rising costs and timelines to bring innovative therapies to market – not to mention the COVID-19 pandemic – have accelerated the surge in demand for decentralised clinical trials. ... Adopt agile remote monitoring to keep trials on track. During COVID
-
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
In the context of COVID-19, when healthcare systems are strained and we try to protect those with underlying conditions from the direct and indirect impact of the virus, the need
-
Three ways AI will change healthcare in the next decade
So far, its performance has been promising. Not only has AI enabled policymakers and frontline health workers to trace and limit the spread of Covid-19, but it has also accelerated
-
Growing evidence supports the important role of biosimilars in healthcare
the potential higher risk of COVID-19 complications among cancer patients.
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
In 2014-15, M&A deal values in this sector were $5bn, and in 2018-19, this surged 980% to a combined two-year total of $49bn. ... Much like the rush to find a COVID-19 vaccine that dominates headlines worldwide, not every company involved will be able to
More from intelligence
Approximately 6 fully matching, plus 65 partially matching documents found.
Latest from PMHub
-
Live Webinar: COVID-19 Has Changed Live Events Forever!
We invite you to join Impetus Digital and the Medical Affairs Professional Society (MAPS) on February 19, 10 am EST, for a thought-provoking webinar around the future of virtual events. ... OVERVIEW AND OBJECTIVES:. COVID-19 has made us rethink the way
-
Live Webinar: Can Science Save Us?
Fireside Chat with Dr. Mark Poznansky, Founder of Saved by Science. Dr. Mark Poznansky, Founder/Blogger at Saved By Science, will join Natalie Yeadon for this live Fireside Chat. They will explore a range of topics, including Mark’s work to
-
Live Webinar: Holistic Digital Health Engagement and Risk Quantification
in the COVID-19 era.
-
Lockdown 3: Why patients cannot afford another pause in pharma-sponsored support
Just like pharma, patient groups have played a vital role in the response to the COVID-19 pandemic. ... Conduct survey / literature review to assess state of play about the impact of COVID-19 in your priority therapeutic area.
-
Communicating the vaccine: how do we get the story right?
Webinar discusses the communications challenges of persuading the public to be vaccinated against COVID-19. ... What are the communications challenges around persuading the public to be vaccinated against COVID-19?
More from PMHub
Approximately 63 fully matching, plus 118 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- New study identifies drugs that are safe to use in COVID-19 treatment
- Biogen advances Spinraza study in SMA patients treated with Novartis’ Zolgensma
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- Experimental Chinese COVID-19 vaccine is safe, according to researchers
- UK pharmacies to begin administering COVID-19 vaccinations
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
